Flavonoids suppress androgen-independent human prostate tumor proliferation

被引:133
|
作者
Knowles, LM
Zigrossi, DA
Tauber, RA
Hightower, C
Milner, JA
机构
[1] Penn State Univ, Grad Program Nutr, University Pk, PA 16802 USA
[2] Penn State Univ, Dept Nutr, University Pk, PA 16802 USA
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2000年 / 38卷 / 01期
关键词
D O I
10.1207/S15327914NC381_16
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present studies compared the effects of selected bioflavonoids on the proliferation of androgen-independent human prostatic tumor cells (PC-3). Complete growth retardation was observed in PC-3 cells treated with 100 muM quercetin, kaempferol, and luteolin, while isomolar genistein, apigenin, and myricetin suppressed PC-3 proliferation by 73% 70%, and 59% respectively (p < 005). Naringenin and rutin were not as effective and inhibited growth by < 25%. Exposure to increasing concentrations of quercetin and kaempferol led to a dose-dependent decrease in proliferation. Refeeding kaempferol-treated cells (50 muM) complete medium without the flavonoid resulted in a return toward control growth rates. Similar growth recovery was not observed in quercetin-treated cells. The antiproliferative response of PC-3 cells to quercetin and kaempferol was additive when supplemented to the medium at 25 muM. A block in G(2)-to-M phase progression was observed after the addition of 25 muM kaempferol. When quercetin reached 100 muM, an increase in the proportion of cells in the S phase became apparent within 24 hours. Apoptosis was not evident, even when concentrations of quercetin or kaempferol were raised to 100 muM. The present studies suggest that alterations in cell cycle progression contribute significantly to the antiproliferative effects of quercetin and kaempferol in PC-3 cells.
引用
收藏
页码:116 / 122
页数:7
相关论文
共 50 条
  • [41] Current chemotherapeutic approaches for androgen-independent prostate cancer
    Rumohr, Jon A.
    Chang, Sam S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (06) : 529 - 533
  • [42] Differential gene expression in androgen-independent prostate tumors
    Nature Clinical Practice Oncology, 2005, 2 (4): : 176 - 177
  • [43] Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase
    Sumitomo, M
    Asano, T
    Asakuma, J
    Asano, T
    Nanus, DM
    Hayakawa, M
    CLINICAL CANCER RESEARCH, 2004, 10 (01) : 260 - 266
  • [44] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    T M Beer
    M Garzotto
    W D Henner
    K M Eilers
    E M Wersinger
    British Journal of Cancer, 2003, 89 : 968 - 970
  • [45] Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer
    Borden, Lester S., Jr.
    Clark, Peter E.
    Lovato, James
    Hall, M. Craig
    Stindt, Diana
    Harmon, Michele
    Mohler, Randi M.
    Torti, Frank M.
    CANCER, 2006, 107 (05) : 1093 - 1100
  • [46] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    Bellmunt, Joaquim
    Albiol, Santiago
    Albanell, Joan
    BJU INTERNATIONAL, 2007, 100 (03) : 490 - 492
  • [47] Signal transduction targets in androgen-independent prostate cancer
    Zhou, J
    Scholes, J
    Hsieh, JT
    CANCER AND METASTASIS REVIEWS, 2001, 20 (3-4) : 351 - 362
  • [48] Mechanisms underlying the development of androgen-independent prostate cancer
    Pienta, KJ
    Bradley, D
    CLINICAL CANCER RESEARCH, 2006, 12 (06) : 1665 - 1671
  • [49] Hyaluronan stimulates transformation of androgen-independent prostate cancer
    Lin, Shi-Lung
    Chang, Donald
    Ying, Shao-Yao
    CARCINOGENESIS, 2007, 28 (02) : 310 - 320
  • [50] Pten inactivation and the emergence of androgen-independent prostate cancer
    Shen, Michael M.
    Abate-Shen, Cory
    CANCER RESEARCH, 2007, 67 (14) : 6535 - 6538